Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: Case report


Özet A., Özet G., Çalişkaner Z., Kömürcü Ş., Öztürk B.

Endocrine Journal, cilt.44, sa.5, ss.715-717, 1997 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 5
  • Basım Tarihi: 1997
  • Doi Numarası: 10.1507/endocrj.44.715
  • Dergi Adı: Endocrine Journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.715-717
  • Anahtar Kelimeler: Hyperthyroidism, Interferon, Leukemia
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Hayır

Özet

In this case report a patient with thyroid dysfunction who received chronic treatment with interferon-alpha (INF-α) following a diagnosis of chronic myelogenous leukemia (CML) is described. Generally INF-α induced dysthyroidism develops in the earlier phase of INF-α treatment. This is a case report of thyroid dysfunction which occurred 4 years after the patient began to receive INF-α administration. In addition, INF-α was administered to this patient for a longer period than those reported in the literature.